Investigating the Vascular Phenotype of Subcutaneously and Orthotopically Propagated PC3 Prostate Cancer Xenografts Using Combined Carbogen Ultrasmall Superparamagnetic Iron Oxide MRI-Reference-Cited by-同舟云学术

Investigating the Vascular Phenotype of Subcutaneously and Orthotopically Propagated PC3 Prostate Cancer Xenografts Using Combined Carbogen Ultrasmall Superparamagnetic Iron Oxide MRI

Published:2016-10 Issue:5 Volume:25 Page:237-243
ISSN:0899-3459
Container-title:Topics in Magnetic Resonance Imaging
language:en
Short-container-title:

Author:

Burrell Jake S.,Walker-Samuel Simon,Boult Jessica K.R.,Baker Lauren C.J.,Jamin Yann,Halliday Jane,Waterton John C.,Robinson Simon P.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology, Nuclear Medicine and imaging

Reference44 articles.

1. Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil;Jung;Magn Reson Imaging,1995

2. Investigating temporal fluctuations in tumor vasculature with combined carbogen and ultrasmall superparamagnetic iron oxide particle (CUSPIO) imaging;Burrell;Magn Reson Med,2011

3. Evaluation of novel combined carbogen USPIO (CUSPIO) imaging biomarkers in assessing the antiangiogenic effects of cediranib (AZD2171) in rat C6 gliomas;Burrell;Int J Cancer,2012

4. Finding the tumor copycat. Therapy fails, patients don’t;Ellis;Nat Med,2010

5. Finding the tumor copycat: approximating a human cancer;Van Dyke;Nat Med,2010

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD46 targeted 212Pb alpha particle radioimmunotherapy for prostate cancer treatment;Journal of Experimental & Clinical Cancer Research;2023-03-11

2. CD46 targeted²¹²Pb alpha particle radioimmunotherapy for prostate cancer treatment;2022-10-18

3. Validation of miR-20a as a Tumor Suppressor Gene in Liver Carcinoma Using Hepatocyte-Specific Hyperactive piggyBac Transposons;Molecular Therapy - Nucleic Acids;2020-03

4. Comparative Study of Subcutaneous and Orthotopic Mouse Models of Prostate Cancer: Vascular Perfusion, Vasculature Density, Hypoxic Burden and BB2r-Targeting Efficacy;Scientific Reports;2019-07-31